Outlook for tuberculosis elimination in California: An individual-based stochastic model

Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model

(2017) Abriana Tasillo et al.   JAMA Internal Medicine

Leveling of Tuberculosis Incidence — United States, 2013–2015

(2016) Jorge L. Salinas et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Towards tuberculosis elimination: an action framework for low-incidence countries

(2015) Knut Lönnroth et al.   EUROPEAN RESPIRATORY JOURNAL

Thresholds for the cost–effectiveness of interventions: alternative approaches

(2015) Elliot Marseille et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012

(2015) Roque Miramontes et al.   PLoS One

The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

(2014) Marita Cross et al.   ANNALS OF THE RHEUMATIC DISEASES

The ongoing challenge of latent tuberculosis

(2014) H. Esmail et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup

(2013) K. M. Shea et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection

(2013) Dick Menzies et al.   ANNALS OF INTERNAL MEDICINE

Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program

(2013) Jie Zhang et al.   ARTHRITIS CARE & RESEARCH

Modelling tuberculosis trends in the USA

(2012) A. N. HILL et al.   EPIDEMIOLOGY AND INFECTION

Healthcare Utilization and Comorbidity Burden among Children and Young Adults in the United States with Systemic Lupus Erythematosus or Inflammatory Bowel Disease

(2012) Sudeep Karve et al.   JOURNAL OF PEDIATRICS

Programmatic Impact of QuantiFERON-TB Gold In-Tube Implementation on Latent Tuberculosis Diagnosis and Treatment in a Public Health Clinic

(2012) Maunank Shah et al.   PLoS One

Programmatic impact of using QuantiFERON® -TB Gold in routine contact investigation activities

(2011) J.A. Grinsdale et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

(2011) Timothy R. Sterling et al.   NEW ENGLAND JOURNAL OF MEDICINE

Undocumented immigrants and their use of medical services in Orange County, California

(2011) Leo R. Chavez   SOCIAL SCIENCE & MEDICINE

Latent TB Infection Treatment Acceptance and Completion in the United States and Canada

(2009) C. Robert Horsburgh et al.   CHEST

Personal and Societal Health Quality Lost to Tuberculosis

(2009) Thaddeus L. Miller et al.   PLoS One

Tuberculosis and Illicit Drug Use: Review and Update

(2008) Robert G. Deiss et al.   CLINICAL INFECTIOUS DISEASES

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY